Quality agreements in Japan play a crucial role in drug quality audits by clearly defining responsibilities, expectations, and standards between pharmaceutical companies and their partners. They ensure compliance with regulatory requirements, facilitate communication, and help identify potential risks, thereby enhancing the overall quality and safety of pharmaceutical products during audits.